Описание деятельности
Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in Hematology and Oncology. Spectrum currently markets five hematology/oncology drugs, and expects an FDA decision on another hematology drug later this year. Additionally, Spectrum's pipeline includes three drugs targeting blockbuster markets in advanced stages of clinical development. Spectrum's strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies.
Правление & Наблюдательный совет
| Исполнительный директор |
| Joseph Turgeon |
| Правление |
| Kurt Gustafson, Francois Lebel, Keith M. McGahan, Thomas J. Riga |
| Наблюдательный совет |
| William L. Ashton, Bernice R. Welles, Dolatrai M. Vyas, Jeffrey L. Vacirca, Joseph W. Turgeon, Nora Brennan, Seth H.Z. Fischer |
Данные компании
| Имя: |
Spectrum Pharmaceuticals Inc. |
| Адрес: |
11500 S. Eastern Avenue, Suite 240,Henderson, NV 89052, USA |
| Телефон: |
+1-702-935-6300 |
| Факс: |
+1-702-260-7405 |
| E-mail: |
-
|
| Интернет: |
https://www.sppirx.com/ |
| Индустрия: |
Biotechnology |
| Сектор: |
Biotechnology |
| Подсектор: |
Biotechnology |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
61.22% |
| Дата IPO: |
- |
Связи с инвесторами
| Имя: |
Shiv Kapoor |
| IR телефон: |
- |
| IR-факс: |
- |
| IR e-mail: |
IR@sppirx.com
|
